Results 101 to 110 of about 8,279 (219)
Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.ABSTRACT Background Dupilumab is effective for moderate‐to‐severe atopic dermatitis (AD), but sustained disease control after treatment discontinuation remains challenging. House dust mite allergen immunotherapy (HDM‐AIT) may provide disease‐modifying effects in sensitized patients, but the added value of combining HDM‐AIT with dupilumab remains ...
Jiale Lian +3 more
wiley +1 more source
Clinical Heterogeneity in Adult Rhinitis: Symptom‐Sensitization Concordance and Asthma Burden
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.Rhinitis symptoms and systemic allergen‐specific IgE sensitization identified distinct adult clinical phenotypes. Concordant positive adults had the highest asthma burden, whereas symptom‐only adults showed greater sinonasal and sleep‐related burden. These findings highlight clinically relevant heterogeneity in adult rhinitis.
Chong Wang +3 more
wiley +1 more source
The Evolution of Semiconductor Devices: From Transistors to Quantum and Neuromorphic Computing
physica status solidi (RRL) – Rapid Research Letters, Volume 20, Issue 8, August 2026.This review presents the evolution of semiconductor devices from BJTs to fin field‐effect transistors (FinFETs), nanowire, and carbon nanotube transistors. It highlights emerging materials, including SiC and GaN, and examines neuromorphic and quantum computing, industry applications, performance benchmarks, challenges, and future directions.
Manoharan Subramanian +6 more
wiley +1 more source
Casein as rare elicitor of food allergy dependent on augmentation factors ‐ A case report
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Charlotte Jasmin Kiani +5 more
wiley +1 more source
Quality and Consistency of Penicillin Allergy Delabelling Guidelines: A Systematic Review
Clinical &Experimental Allergy, Volume 56, Issue 8, Page 867-880, August 2026.Eighteen penicillin allergy delabelling guidelines from 12 countries were reviewed. There is consensus for staged risk‐based testing, with emerging support for direct oral challenge in low‐risk patients and expanded non‐specialist roles. Overall guideline quality was low, with major gaps in methodological rigour, stakeholder involvement, and ...
Jessie He +8 more
wiley +1 more source
Clinical &Experimental Allergy, Volume 56, Issue 8, Page 881-892, August 2026.Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić +10 more
wiley +1 more source
Clinical &Experimental Allergy, Volume 56, Issue 8, Page 893-903, August 2026.3 years follow‐up study to a DBPC dose‐finding trial investigating subcutaneous immunotherapy with T502 in birch‐pollen induced allergic rhinoconjunctivitis. 154 birch‐pollen allergic adults received short‐course treatment of 10,000 mTU/mL of T502 for 2 years and were observed during the next season without treatment.
Ralph Mösges +15 more
wiley +1 more source
Nanophotonics, Volume 15, Issue 14, 27 July 2026.Integrated optical phased arrays are emerging as scalable engines for solid‐state beam steering and programmable wavefront control. This Review maps the field from beam‐steering principles and core building blocks to material platforms, system‐level bottlenecks, and application frontiers, highlighting how heterogeneous integration, aperiodic ...
Jingwei Li +7 more
wiley +1 more source